Community site infrastructure paradigms in ISPY COVID-19
| Types of hospitals | Status | Pharmacy | Coordinators | Compensation | Geographic |
| Academic or community centres with research capacity and experience | I-SPY COVID site | Investigational Pharmacy | I-SPY COVID site | Full | NA |
| Academic or community centres with ICU care but limited research infrastructure | Partnership with one of the I SPY COVID sites | Clinical pharmacist trained by investigational pharmacy partner | In partnership with one of the I-SPY COVID sites | Shared | No |
| Community hospitals without sufficient ICU care for severe COVID-19 | Transfer patients to nearby I SPY COVID site | Transfer to I-SPY site | Partner with I-SPY site. Work to identify eligible patients and coordinate transfer | Shared | Yes |